Combined radiation therapy and chemotherapy for carcinoma of the cervix
- PMID: 11324770
Combined radiation therapy and chemotherapy for carcinoma of the cervix
Abstract
Cervical cancer is the third most common cancer affecting women worldwide. Surgery, radiation therapy, and chemotherapy have been used in various settings in an effort to improve survival rates of patients with cervical cancer. Recent cooperative clinical trials have demonstrated a benefit from the concurrent use of chemotherapy and radiation therapy to treat cervical cancer. These studies have provided the most significant improvement in the treatment of locally advanced disease in more than 30 years. This review summarizes studies of sequential and concurrent combinations of chemotherapy and radiation therapy for the treatment of cervical cancer, as well as the recent controversies related to this treatment.
Similar articles
-
A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.Bull Cancer. 2005 Feb;92(2):E19-24. Bull Cancer. 2005. PMID: 15749639
-
Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.Nat Clin Pract Oncol. 2006 May;3(5):248-55. doi: 10.1038/ncponc0486. Nat Clin Pract Oncol. 2006. PMID: 16683003 Review.
-
Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.Strahlenther Onkol. 2001 Dec;177(12):635-40. Strahlenther Onkol. 2001. PMID: 11789401 Review.
-
Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.Gynecol Obstet Invest. 2008;65(2):96-103. doi: 10.1159/000108600. Epub 2007 Sep 19. Gynecol Obstet Invest. 2008. PMID: 17878736 Review.
-
Chemotherapy for recurrent cervical cancer.Cancer Treat Rev. 2008 Nov;34(7):603-13. doi: 10.1016/j.ctrv.2008.05.006. Epub 2008 Jul 26. Cancer Treat Rev. 2008. PMID: 18657909 Review.
Cited by
-
Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.Curr Oncol. 2024 Apr 29;31(5):2508-2526. doi: 10.3390/curroncol31050188. Curr Oncol. 2024. PMID: 38785469 Free PMC article. Review.
-
A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.Invest New Drugs. 2003 Nov;21(4):453-7. doi: 10.1023/a:1026255403046. Invest New Drugs. 2003. PMID: 14586213 Clinical Trial.
-
Local Disease-Free Survival and Disease-Free Survival in Locally Advanced Cervical Cancer Diagnosed and Treated in Bihor County, Romania.Cureus. 2024 Jul 29;16(7):e65629. doi: 10.7759/cureus.65629. eCollection 2024 Jul. Cureus. 2024. PMID: 39205752 Free PMC article.
-
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.Immunology. 2008 Jan;123(1):129-38. doi: 10.1111/j.1365-2567.2007.02737.x. Epub 2007 Nov 20. Immunology. 2008. PMID: 18028372 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical